Home > Financial Ratios > DIVIS LABORATORIES

DIVIS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -6.23-32.1036.7145.25-0.78

What is the latest Core EBITDA Growth ratio of DIVIS LABORATORIES ?

The latest Core EBITDA Growth ratio of DIVIS LABORATORIES is -6.23 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-6.23
Mar2023-32.10
Mar202236.71
Mar202145.25
Mar2020-0.78

How is Core EBITDA Growth of DIVIS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 -6.23
Negative
Mar2023 -32.1
Negative
Mar2022 36.71
-18.87
Mar2021 45.25
Positive
Mar2020 -0.78 -

Other Financial Ratios of DIVIS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹148,491.5 Cr 1.9% 1.5% 41.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,900.0 Cr -1.3% 4.7% 3.3% Stock Analytics
CIPLA ₹118,166.0 Cr 3.4% 0.1% -3.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,849.0 Cr -4.8% 1.9% 20.3% Stock Analytics
MANKIND PHARMA ₹97,009.6 Cr -4% 4% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹92,553.6 Cr -0.1% -1% -11.3% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

1.9%

1.5%

41.9%

SENSEX

-1.5%

1.1%

1.2%


You may also like the below Video Courses